JP2013528622A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528622A5
JP2013528622A5 JP2013513360A JP2013513360A JP2013528622A5 JP 2013528622 A5 JP2013528622 A5 JP 2013528622A5 JP 2013513360 A JP2013513360 A JP 2013513360A JP 2013513360 A JP2013513360 A JP 2013513360A JP 2013528622 A5 JP2013528622 A5 JP 2013528622A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cadherin
optionally
composition according
der
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013513360A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013528622A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/039002 external-priority patent/WO2011153397A2/en
Publication of JP2013528622A publication Critical patent/JP2013528622A/ja
Publication of JP2013528622A5 publication Critical patent/JP2013528622A5/ja
Pending legal-status Critical Current

Links

JP2013513360A 2010-06-04 2011-06-03 炎症性障害の処置 Pending JP2013528622A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35150510P 2010-06-04 2010-06-04
US61/351,505 2010-06-04
PCT/US2011/039002 WO2011153397A2 (en) 2010-06-04 2011-06-03 Treatment of inflammatory disorders

Publications (2)

Publication Number Publication Date
JP2013528622A JP2013528622A (ja) 2013-07-11
JP2013528622A5 true JP2013528622A5 (cg-RX-API-DMAC7.html) 2014-07-24

Family

ID=45067307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013513360A Pending JP2013528622A (ja) 2010-06-04 2011-06-03 炎症性障害の処置

Country Status (7)

Country Link
US (1) US20130209476A1 (cg-RX-API-DMAC7.html)
EP (1) EP2575883B1 (cg-RX-API-DMAC7.html)
JP (1) JP2013528622A (cg-RX-API-DMAC7.html)
AU (1) AU2011261323A1 (cg-RX-API-DMAC7.html)
CA (1) CA2805270C (cg-RX-API-DMAC7.html)
IL (1) IL223385B (cg-RX-API-DMAC7.html)
WO (1) WO2011153397A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
US11097005B2 (en) 2014-12-15 2021-08-24 The Brigham And Women's Hospital, Inc. Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity
WO2018013957A1 (en) * 2016-07-14 2018-01-18 Greco Chad Hybrid formulation of responsive polymeric nanocarriers for therapeutic and diagnostic delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610281A (en) 1994-05-03 1997-03-11 Brigham & Women's Hospital, Inc. Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes
US7481999B2 (en) * 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US6787136B1 (en) * 1999-09-03 2004-09-07 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
CN101613406A (zh) * 2002-06-06 2009-12-30 肿瘤疗法科学股份有限公司 与人结肠癌相关的基因和多肽
CA2522957C (en) * 2003-04-23 2013-10-22 Medarex, Inc. Compositions and methods for the therapy of inflammatory bowel disease
WO2005007175A2 (en) * 2003-06-09 2005-01-27 The Brigham And Women's Hospital, Inc. Cadherin directed molecular and cellular localization
MY162179A (en) * 2004-04-01 2017-05-31 Elan Pharm Inc Steroid sparing agents and methods of using same
CN101918836B (zh) * 2007-05-08 2014-04-30 皮可贝拉有限责任公司 诊断和治疗前列腺癌和肺癌的方法
JP2011514318A (ja) * 2008-02-11 2011-05-06 ノバルティス アーゲー カドヘリン11(cdh11)アンタゴニストの使用方法
EP2393787B1 (en) * 2009-02-09 2018-01-24 Georgetown University Cadherin-11 inhibitors and methods of use thereof
US8877188B2 (en) * 2010-05-04 2014-11-04 The Brigham And Women's Hospital, Inc. Detection and treatment of non-dermal fibrosis
KR20130107203A (ko) * 2010-05-04 2013-10-01 더 브리검 앤드 우먼즈 하스피털, 인크. 섬유증의 검출 및 치료

Similar Documents

Publication Publication Date Title
Qu et al. Stimulation of sigma‐1 receptor protects against cardiac fibrosis by alleviating IRE1 pathway and autophagy impairment
Fanelli et al. Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-α1
Matsumoto et al. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model
van Koppen et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease
JP2014526441A5 (cg-RX-API-DMAC7.html)
NZ599315A (en) Antibody therapeutics with local activity in the digestive tract
JP2016517888A5 (cg-RX-API-DMAC7.html)
Momcilović et al. CXCL12 in control of neuroinflammation
US20230129866A1 (en) Methods of treating respiratory disease with deupirfenidone
CN115227826A (zh) Rxr激动剂和甲状腺激素在制备用于治疗自身免疫疾病的药物中的用途
Martinez et al. Anesthesia for kidney transplantation—a review
WO2021183774A1 (en) Treating acute respiratory distress
Su et al. Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt/β-catenin pathway
Ai et al. Paeonol ameliorates diabetic nephropathy by promoting TFEB-mediated lysosome biogenesis and lipophagy
Garcia-Dorado et al. Primary results of the PROMISE trial: myocardial protection with intracoronary adenosine given before reperfusion in patients with STEMI
van Echteld et al. A view on imaging in drug research and development for respiratory diseases
CN106714842A (zh) 包含双重PI3K δ‑γ激酶抑制剂和皮质类固醇的治疗方法及组合物
WO2023001305A1 (zh) 缓解或治疗纤维化性疾病的药物组合物或药盒及其应用
Sababathy et al. A ‘One Stone, Two Birds’ Approach with Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome and Type Ii Diabetes Mellitus
CN104644620B (zh) 化合物xl‑001在制备治疗慢性肾脏病的药物中的用途
JP2014079188A (ja) 無菌性慢性前立腺炎非ヒトモデル動物、頻尿非ヒトモデル動物およびこれらを用いた被験物質の評価方法
Church et al. The artificial placenta rescues premature lambs from Ventilatory failure
Suda et al. Spherical sulfated cellulose adsorbs high-mobility-group box chromosomal protein 1 in vitro and in vivo
Lieberman et al. Preliminary Findings from the Phase 2 EPPIK Study of Sparsentan in Pediatric Patients with Selected Proteinuric Glomerular Diseases: SA-OR84
Zhou et al. Therapeutic Effects of PXR Agonists in a Novel Adenine‐Induced HFsnEF Mouse Model